Senial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis

被引：10

作者：

Anon, Jack B.

Paglia, Margaret

Xiang, Jim

Ambrose, Paul G.

Jones, Ronald N.

Kahn, James B. ^{[1
]}

机构：

[1] PriCara, Med Affairs, Unit Ortho McNeil Inc, Raritan, NJ 08869 USA

[2] Univ Pittsburgh, Dept Otolaryngol, Coll Med, Erie, PA 16508 USA

[3] Ortho McNeil Janssen Sci Affairs, Clin Project Management, LLC, Raritan, NJ 08869 USA

[4] Ortho McNeil Janssen Sci Affairs, Quantitat Methodol, LLC, Raritan, NJ 08869 USA

[5] Cognigen Corp, Dept Clin Pharmacol, Buffalo, NY 14221 USA

[6] JMI Labs, N Liberty, IA 52317 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2007年 / 57卷 / 01期

关键词：

levofloxacin; maxillary sinusitis; sinus aspirate;

D O I：

10.1016/j.diagmicrobio.2006.10.019

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

This study assessed daily aspirate samples from an indwelling sinus catheter during high-dose, short-course levofloxacin (750 mg daily x 5 days) treatment of acute maxillary sinusitis. Pathogens were isolated from 4 of 18 recruited patients. Bacteriologic eradication occurred within 24 h for 3 patients and 72 h for the 4th. (c) 2007 Elsevier Inc. All rights reserved.

引用

页码：105 / 107

页数：3

共 15 条

[1] Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults [J].

Adelglass, J ;

DeAbate, CA ;

McElvaine, P ;

Fowler, CL ;

LoCocco, J ;

Campbell, T .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1999, 120 (03) :320-327

[2]

Adelglass J, 1998, PHARMACOTHERAPY, V18, P1255

[3] Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis [J].

Ambrose, PG ;

Anon, JB ;

Owen, JS ;

Van Wart, S ;

McPhee, ME ;

Bhavnani, SM ;

Piedmonte, M ;

Jones, RN .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (11) :1513-1520

[4] Maxillary sinus puncture and culture in the diagnosis of acute rhinosinusitis: The case for pursuing alternative culture methods [J].

Benninger, MS ;

Appelbaum, PC ;

Denneny, JC ;

Osguthorpe, DK ;

Stankiewicz, JA .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2002, 127 (01) :7-12

[5]

*CDC, 2005, MMWR-MORBID MORTAL W, V54, P631

[6]

*CLIN LAB STAND I, 2006, M100S16 CLSI

[7] Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens [J].

Dunbar, LM ;

Khashab, MM ;

Kahn, JB ;

Zadeikis, N ;

Xiang, JX ;

Tennenberg, AM .

CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (04) :555-563

[8] Short treatment durations for acute bacterial rhinosinusitis: Five days of gemifloxacin versus 7 days of gemifloxacin [J].

Ferguson, BJ ;

Anon, J ;

Poole, MD ;

Hendrick, K ;

Gilson, M ;

Seltzer, EG .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2002, 127 (01) :1-6

[9] Clinical implications of 750mg, 5-day levofloxacin for the treatment of community acquired pneumonia [J].

File, TM ;

Milkovich, G ;

Tennenberg, AM ;

Xiang, JX ;

Khashab, MM ;

Zadeikis, N .

CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) :1473-1481

[10] Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis [J].

Gehanno, P ;

Berche, P ;

Danon ;

Darmon ;

Car ;

Amsellem ;

Timsit ;

Amsellem ;

Nemi ;

Tlili ;

Trottin ;

Cambriel ;

Levy ;

Meaux ;

Lafosse ;

Blassin ;

Hamman ;

Lefranc ;

Marsac ;

Reboul ;

Donnadieu ;

Lefebvre ;

AroniodeRon ;

DeloixVericel ;

Duboux ;

Flieder ;

Rousselet ;

Samson ;

Vericel ;

Tsigaridis ;

Popot ;

Jacquin ;

Huart ;

Ebbo ;

Dufour ;

Cornubert ;

Baculard ;

Meunier ;

LopezMoya ;

Vigneron ;

Bonnard ;

Isasa ;

Bourrel ;

Agustin ;

Assous ;

Banal ;

Barrier ;

Betsch ;

Bringart ;

Cassat .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 :105-114

← 1 2 →